TopU-LBVS Multi-Target Benchmark for Ligand-Based Virtual Screening
September 25, 2026
TopU-LBVS introduces a benchmark for ligand-based virtual screening across 93 protein targets using property-matched, structurally similar decoys. It utilizes a 1:40 active-to-decoy ratio to prevent models from using simple physicochemical shortcuts.
HOW THIS AFFECTS YOU
●
researcherUse this benchmark to test if your screening models are actually learning bioactivity rather than exploiting dataset biases.
●
healthImproved screening benchmarks can accelerate the reliability of early-stage drug discovery pipelines.